Angiotensin-converting enzyme inhibitors have adverse effects in anti-angiogenesis therapy for hepatocellular carcinoma.
Zhang S, Cao M, Hou Z, Gu X, Chen Y, Chen L, Luo Y, Chen L, Liu D, Zhou H, Zhu K, Wang Z, Zhang X, Zhu X, Cui Y, Li H, Guo H, Zhang T.
Zhang S, et al. Among authors: zhu x, zhu k.
Cancer Lett. 2021 Mar 31;501:147-161. doi: 10.1016/j.canlet.2020.12.031. Epub 2020 Dec 28.
Cancer Lett. 2021.
PMID: 33383154